Marathon gets the Shkreli treatment from industry after $89K drug dust up

(credit: ccPixs.com) Last week, Marathon Pharmaceuticals announced that it would start selling an old steroid drug that treats Duchenne muscular dystrophy for a whopping $ 89,000 per year of treatment. That’s a steep increase from the $ 1,200-per-year generic version that families could import from other countries. The standard reactions ensued: patient groups were outraged, […]

Drug maker pushes pause on $89K drug after outcry

Enlarge / Sen. Bernie Sanders (I-VT) (credit: Getty | Chip Somodevilla /) In an unexpected move, Marathon Pharmaceuticals announced Monday that it is pausing the roll-out of its now FDA-approved drug for Duchenne muscular dystrophy—which has an $ 89,000-per-year list price. The announcement comes in the wake of intense outcry from patients, the public, and […]